VEGFA and glioblastoma: The small molecule CSF-1 R inhibitor BLZ945, which is a CSF-1 R inhibitor, can enhance a pro-inflammatory M1 phenotype of macrophages and prolong survival in platelet-derived growth factor (PDGF)–driven genetic glioblastoma models, as well as reduce VEGF-driven proliferation of macrophages.